絞り込み

16731

広告

「"Dyke J "[Author]」の検索結果

45件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Minimal PD-1 expression in mouse and human NK cells under diverse conditions.

High-fidelity detection and sorting of nanoscale vesicles in viral disease and cancer.

Normative data of muscle fiber diameter of vastus lateralis during childhood: a field test.

Methodology for evaluating and comparing flow cytometers: A multisite study of 23 instruments.

Knockdown of Crispld2 in zebrafish identifies a novel network for nonsyndromic cleft lip with or without cleft palate candidate genes.

Robust upward dispersion of the neutron spin resonance in the heavy fermion superconductor Ce1-xYbxCoIn5.

Accuracy and sampling error of two age estimation techniques using rib histomorphometry on a modern sample.

Aza-macrocyclic complexes of the Group 1 cations - synthesis, structures and density functional theory study.

Adolescent-specific patterns of behavior and neural activity during social reinforcement learning.

Ventilatory Control in ALS.

Long-Term Expression and Safety of Administration of AAVrh.10hCLN2 to the Brain of Rats and Nonhuman Primates for the Treatment of Late Infantile Neuronal Ceroid Lipofuscinosis.

Laser therapy in veterinary medicine.

Hydrophilization of Magnetic Nanoparticles with Modified Alternating Copolymers. Part 2: Behavior in solution.

The prediction of learning in family therapy training programs*.

Identification of novel host-oriented targets for Human Immunodeficiency Virus type 1 using Random Homozygous Gene Perturbation.

Magnetic nanoparticles with functional silanes: evolution of well-defined shells from anhydride containing silane.

The use of Random Homozygous Gene Perturbation to identify novel host-oriented targets for influenza.

The patient safety journey.

Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis.

Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer.

  1. 1
  2. 2
  3. 3
Sort by
※並べ替えは表示に時間がかかります